Clifford Davis
Papers
1
Total Citations
30
H-Index
1
About
Clifford Davis is a pioneering figure in the field of noninvasive oncologic interventions, with a primary focus on the clinical translation of histotripsy for the treatment of liver tumors. His major contribution is the leadership of the landmark #HOPE4LIVER single-arm pivotal trial, which represents the first comprehensive evaluation of histotripsy—a novel, non-thermal focused ultrasound technology that mechanically liquefies targeted tissue—for both primary and metastatic hepatic malignancies. This groundbreaking work, published in 2025 and already garnering 30 citations, has established a new paradigm in tumor ablation by demonstrating that precise, image-guided acoustic energy can achieve effective tumor destruction without the heat-related side effects of traditional thermal therapies. Davis’s research is distinguished by its rigorous assessment of 1-year clinical outcomes, providing critical evidence for the safety and efficacy of this approach. His achievements have positioned histotripsy as a potential game-changer in liver cancer management, offering patients a noninvasive alternative that preserves healthy liver parenchyma. Through this work, Davis is shaping the future of interventional oncology, bridging the gap between engineering innovation and tangible patient benefit.
Research Focus
Key Achievements
Top Papers
- 1